Showing results (121-130 of 522) with videos related to
Sort By:
Pageof 53
The Lancet. Oncology|September 4, 2025
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trialJordi Remon, Paolo Bironzo, Nicolas Girard, et al.JCO Precision Oncology|September 11, 2020
Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non-Small-Cell Lung CancerJordi Remon, Ludovic Lacroix, Cecile Jovelet, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2022
Emerging Systemic Treatment Perspectives on Brain Metastases: Moving Toward a Better Outlook for PatientsChristopher Alvarez-Breckenridge, Jordi Remon, Yolanda Piña, et al.European Journal of Cancer (Oxford, England : 1990)|March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMAJordi Remon, Benjamin Lacas, Roy Herbst, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 12, 2025
Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung CancerAnne Opalikhin, Scott Friedland, Maria Lucia Madariaga, et al.La Revue Du Praticien|December 5, 2018
[Thymic tumors]Nicolas Girard, Claire Merveilleux Du Vignaux, Thierry Molina, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
The evolving role of histology in the management of advanced non-small-cell lung cancerCorey J Langer, Benjamin Besse, Antonio Gualberto, et al.Critical Reviews in Oncology/Hematology|June 20, 2012
Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkersStéphane Vignot, Benjamin Besse, Fabrice André, et al.Bulletin Du Cancer|November 21, 2015
[Nivolumab, a new hope in non-small cell lung cancer]Ronan Flippot, Vincent Fallet, Benjamin Besse, et al.Bulletin Du Cancer|February 4, 2006
[EGFR-targeted therapies: what's new?]Stéphane Vignot, Benjamin Besse, Jean-Charles Soria, et al.Pageof 53